![]() |
Own Slots | ||
---|---|---|
Slot Name | Value | |
![]() |
Alternatives | |
![]() |
CanImprove | Mortality, Morbidity |
![]() |
CautionWithMedicationsUsed | |
![]() |
Comment | |
![]() |
Contraindication | |
![]() |
CouldBeRelatedTo | |
![]() |
Cui | C0126174 |
![]() |
Definition | An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II. |
![]() |
DespiteReceivingTreatment | |
![]() |
DoNotUseWithMedicationGroup | |
![]() |
EspeciallyEffectiveAgainst | |
![]() |
Improves | |
![]() |
Incrementsmgday | |
![]() |
InitiatingDose | |
![]() |
MaintenanceDose | |
![]() |
MaximumRecommendedDailyDose | |
![]() |
MeanDailyDose | |
![]() |
RelevantSignOrSymptom | |
![]() |
SideEffect | |
![]() |
Synonyms | |
![]() |
TargetDose | 50-100 mg daily |
![]() |
TitrationPeriod | |
![]() |
TreatmentStatus | |
![]() |
Treats | |
![]() |
UMLSSynonyms | |
![]() |
UsedTogetherWithMedication | |
![]() |
UsedWithMedicationGroup | Adrenergic_beta-antagonists |
![]() |
UseWhenExistsIntoleranceOf | |
![]() |
UseWithTest |